Ocugen's shares rise 13% on potential effectiveness of Covaxin in three COVID-19 variants
(May 3) Ocugen announcesthat in a new study, scientists have found that Covaxin demonstrated potenti
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email:uservice@ttm.financial